Cooperative Agreement 2321834
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$998K
Federal Agency
National Science Foundation
Awardee
Nanopath Inc. (MURFWBMTD7F7)
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Cambridge, MA 02139, USA
Similar Awards
Nanopath Inc. received a $255,874 Project Grant award from the National Science Foundation Division of Industrial Innovation on January 1, 2022 for its "Integrated Point-of-Care System for Rapid Pathogen Identification in Urinary Tract Infections" project. The award is part of the NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and education. Under the award, Nanopath will develop an integrated...
This $305,000 Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a point-of-care diagnostic platform by Resonantia Diagnostics, Inc. that can rapidly identify pathogens and determine their antimicrobial susceptibility within 60 minutes. The key technical objectives of this 1-year project are to: (1) demonstrate accurate antimicrobial susceptibility testing at low pathogen loads, (2)...
This $984,381 Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports Cobio Diagnostics Inc., a for-profit company in Aurora, Colorado, in developing an expanded diagnostic technology for rapidly identifying and determining antimicrobial susceptibility of major bloodborne bacterial pathogens. The project aims to expand on the company's previous Phase I SBIR work by developing new tests capable of...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Anvil Diagnostics Inc. in Cambridge, MA provides $298,646 to develop a rapid diagnostic test for detecting sepsis-causing pathogens in plasma samples. The proposed technology aims to comprehensively identify and quantify a wide range of pathogens from small blood volumes within 4 hours, addressing critical limitations of current sepsis diagnostics. The innovations focus on...
This $991,832 Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel rapid antibiotic susceptibility testing (AST) platform by Astek Diagnostics Inc., a minority-owned small business. The platform is designed to deliver results within one hour for various critical specimen types, including urine, cerebrospinal fluid, and wound effluent. This will enable faster identification...
This National Science Foundation (NSF) CAREER grant, awarded under the Engineering program (CFDA 47.041), provides $242,687 to the University of Massachusetts (UMass) to develop an ultrasensitive nanopore biosensor technology for point-of-care detection of infectious disease biomarkers. The project aims to create a next-generation nanopore sensor with unprecedented sensitivity, robustness, and reproducibility to enable rapid, accurate, and multiplexed quantification of circulating proteomics...
This Project Grant award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $305,000 to Giant Biosystems Inc., a small disadvantaged and woman-owned business, to develop a rapid point-of-care antimicrobial susceptibility testing (AST) kit. The goal is to create a platform that can generate actionable AST results within 6-9 hours, compared to the 3-5 day turnaround of current methods. This will enable physicians to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This $274,362 Project Grant awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel molecular diagnostic platform for detecting respiratory diseases, including strep throat, without the need for an expensive table-top device. The platform aims to provide the accuracy of laboratory-based tests for use by non-healthcare professionals in non-clinical settings, enabling rapid and reliable...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Macula Vision Systems Inc., a for-profit organization, supports the development of a novel microscopy platform to automate the interpretation of microbiology lab tests performed in hospitals. The project aims to address the shortage of trained lab technicians by engineering a specialized light source, customized camera, and AI-enabled algorithms to analyze...